GlassScriptPhysician profile
Daniel R Schimmel
NPI 1093974693
$79,046.15
in general payments reported to CMS, 2019-2025
31 companies · $27K in 2025
The $27K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,477 · 2020: $345 · 2021: $1,693 · 2022: $4,025 · 2023: $13K · 2024: $31K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Consulting Fee: $21K · Travel and Lodging: $19K · Food and Beverage: $7,721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,000.00 |
| Consulting Fee | $21,100.00 |
| Travel and Lodging | $18,685.14 |
| Food and Beverage | $7,721.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $20,959.00 | 2021-2025 | Indigo System, Ruby Coil, Penumbra System |
| Inari Medical, INC. | $17,310.56 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $10,956.05 | 2019-2025 | General - Ct_ic, Avvigo Guidance System, General - Therapies |
| Medtronic, INC. | $9,478.37 | 2024-2025 | Symplicity G3, Concertotm |
| Stryker Corporation | $8,915.88 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Inquis Medical, INC. | $6,269.16 | 2025 | Aventus |
| Abiomed | $1,735.96 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $733.62 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia, Evoque |
| Abbott Laboratories | $449.88 | 2022-2025 | Optis, Cardiomems, Perclose Prostyle |
| Cardiovascular Systems INC. | $323.82 | 2020-2022 | |
| Siemens Medical Solutions USA, INC. | $288.54 | 2021 | |
| Cardiva Medical, INC. | $270.04 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Savvywire |
| Asahi Intecc USA, INC. | $193.82 | 2022-2024 | Peripheral Vascular |
| Biosense Webster, INC. | $168.95 | 2023-2024 | Nuvision Ice Catheter |
| Teleflex LLC | $154.02 | 2025 | Orsiro Mission |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $135.21 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $133.16 | 2024-2025 | Lifevest |
| Atricure, INC. | $105.24 | 2025 | Atricure Cryoice Cryoablation System (Cryo2) |
| W. L. Gore & Associates, INC. | $101.57 | 2021-2025 | Gore Cardioform Septal Occluder |
| Angiodynamics, INC. | $88.84 | 2021-2025 | Alphavac |
| Philips North America LLC | $69.02 | 2022-2025 | Igt Devices Undivided, Eagle Eye |
| Lexicon Pharmaceuticals, INC. | $48.26 | 2024 | |
| Biotronik INC. | $35.96 | 2019 | |
| Cordis US Corp. | $30.79 | 2024-2025 | Mynx Control Venous, Mynx Control |
| Biobeat USA INC. | $25.65 | 2024 | Bb-613 Bpm Kit |
| Heartflow, INC. | $22.78 | 2024 | |
| Novo Nordisk INC | $22.06 | 2024 | Wegovy |
| Sandoz INC. | $19.94 | 2025 | Treprostinil |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Schimmel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.